Endovascular Treatment of Focally Dissected Infrarenal Abdominal Aorta with Self-expandable Closed Cell Design Bare Metal Stents

2015 ◽  
Vol 02 (08) ◽  
Author(s):  
Kratovska A Ivanova P ◽  
Ponomarjova S Staudzs K
Keyword(s):  
Endovascular Treatment ◽  
Abdominal Aorta ◽  
Bare Metal Stents ◽  
Metal Stents ◽  
Cell Design ◽  
Bare Metal ◽  
Closed Cell ◽  
Infrarenal Abdominal Aorta

Transbrachial and transfemoral approaches combined with visceral protection for the treatment of juxtarenal aortoiliac occlusive disease: Technical issues and clinical outcomes

Vascular ◽  
2021 ◽  
pp. 170853812110232
Author(s):  
Peixian Gao ◽  
Changliang Li ◽  
Xuejun Wu ◽  
Gang Li ◽  
Dianning Dong ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Bare Metal Stents ◽  
Covered Stent ◽  
Occlusive Disease ◽  
Metal Stents ◽  
Infrarenal Aorta ◽  
Bare Metal ◽  
Stent Grafts ◽  
Aortoiliac Occlusive Disease

Purpose To evaluate the safety and efficacy of transbrachial and transfemoral approaches combined with visceral protection for the endovascular treatment of juxtarenal aortoiliac occlusive disease (AIOD) over an average 19-month follow-up period. Methods In this retrospective analysis, all patients with juxtarenal AIOD at a single institution were reviewed from June 2015 to January 2020. Patient characteristics, angiographic results, and follow-up outcomes were retrospectively recorded. The indications for treatment were critical limb threatening ischemia in 12 patients and bilateral claudication in five patients. Percutaneous access via the left brachial artery was first obtained to recanalize the infrarenal occluded lesions. After that, femoral accesses were achieved. A 4-Fr catheter, a 4 mm balloon, or a 6-Fr 90-cm-long sheath was used to complete visceral artery protection. Results A total of 17 juxtarenal AIOD patients (14 males; mean age, 63.4 ± 8.1 years) underwent endovascular treatment. The technical success rate was 100%. Complete reconstruction was achieved in 15 (88.2%) patients. The infrarenal aorta was reconstructed with kissing covered stent grafts ( n = 7), kissing bare-metal stents ( n = 2), covered stent grafts ( n = 2), bare-metal stents ( n = 1), or the off-label use of iliac limb stent grafts ( n = 5). Renal embolization was found in 3 (17.6%) patients during intraoperative angiography. There was 1 (5.9%) case of distal runoff embolization after CDT and 1 (5.9%) case of left iliac artery rupture. One (5.9%) death occurred due to acute myocardial infarction 20 days after the operation. The average follow-up period was 19.3 ± 16.7 months (range, 1–54 months) in the remaining 16 cases. The renal artery patency rate was 100%. The estimated cumulative primary patency rates were 92.3% at 12 months and 59.3% at 36 months according to the Kaplan–Meier method. Conclusions Transbrachial and transfemoral approaches combined with visceral protection offer a safe and effective alternative to open revascularization for the endovascular treatment of juxtarenal AIOD.

Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?

2017 ◽  
Vol 27 (9) ◽  
pp. 3947-3955 ◽  
Author(s):  
Karla Maria Treitl ◽  
Benedikt Woerner ◽  
Regina Schinner ◽  
Michael Czihal ◽  
Susan Notohamiprodjo ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Bare Metal Stents ◽  
Arterial Occlusive Disease ◽  
Occlusive Disease ◽  
Metal Stents ◽  
Bare Metal ◽  
Stent Design

scholarly journals Bare stent removal in open thoraco-abdominal aortic repair after endovascular treatment with the PETTICOAT technique

2020 ◽  
Vol 31 (2) ◽  
pp. 271-273
Author(s):  
Tetsuro Uchida ◽  
Kimihiro Kobayashi ◽  
Shingo Nakai ◽  
Mitsuaki Sadahiro
Keyword(s):  
Endovascular Treatment ◽  
Aortic Wall ◽  
Bare Metal Stents ◽  
Thoracic Endovascular Aortic Repair ◽  
Metal Stents ◽  
Bare Metal ◽  
Stent Removal ◽  
Aortic Repair ◽  
Separate Branch ◽  
Abdominal Aortic

Abstract The Provisional Extension to Induce Complete Attachment (PETTICOAT) technique using distal bare stents can enhance the effect of proximal thoracic endovascular aortic repair. Here, we present the case of a patient who underwent open surgical conversion and bare stent removal due to progressive thoraco-abdominal aortic enlargement. Previously placed bare-metal stents were embedded deeply in the aortic wall. After explantation of the bare stents, reno-visceral arterial orifices became fragile due to considerable intimal defects, and special care was necessary to make buttons and subsequent separate branch graft anastomoses. As bare stent removal makes open surgical conversion technically difficult, the indication for the PETTICOAT technique should be considered.

scholarly journals Midterm outcomes of endovascular treatment with bare metal stents for Leriche syndrome patients

2020 ◽  
Vol 32 (1) ◽  
pp. 83-88
Author(s):  
Bihui Zhang ◽  
Guochen Niu ◽  
Ziguang Yan ◽  
Yinghua Zou ◽  
Xiaoqiang Tong ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Survival Rates ◽  
Bare Metal Stents ◽  
Target Lesion ◽  
Metal Stents ◽  
Bare Metal ◽  
Free Survival ◽  
Leriche Syndrome ◽  
Related Mortality

Abstract OBJECTIVES This study was undertaken to evaluate the acute and midterm results of endovascular treatment with bare metal stents (BMS) for Leriche syndrome patients. METHODS Patients with Leriche syndrome treated with BMS from August 2008 to May 2017 were included in the study and followed up. The primary endpoints were primary restenosis-free survival rates at 1, 2 and 3 years. The secondary endpoints were secondary restenosis-free and freedom from target lesion revascularization survival rates at 1, 2 and 3 years; technical success rate; complication rate; procedure-related mortality rate; and clinical status improvement at follow-up. RESULTS Twenty patients were included and the follow-up duration was 34.7 ± 18.7 months (0–86 months). The 1-, 2- and 3-year primary restenosis-free survival rates were 94.4%, 88.1% and 73.5% and the secondary patency rates were 94.4%, 94.4% and 86.6%, respectively. The freedom from target lesion revascularization survival rates of patients at 1, 2 and 3 years were 94.4%, 88.1% and 79.3%, respectively. The aortoiliac lesions were successfully treated with BMS bilaterally in 17 patients (85.0%) and unilaterally in another 3 patients (15.0%). The complication rate was 10.0% and the procedure-related mortality rate was 0%. Mean ankle-brachial index increased significantly from 0.43 ± 0.20 before the procedure to 0.95 ± 0.21 after the procedure (P < 0.001), and to 1.00 ± 0.19 at the end of the follow-up (P < 0.001). Improvement in symptoms occurred in most patients soon after the endovascular procedure (95.0%) and at follow-up (88.2%). CONCLUSIONS Endovascular treatment with BMS is effective and safe for patients with Leriche syndrome according to 3-year follow-up results.

Sign in / Sign up

Export Citation Format

Share Document